These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10160488)

  • 1. Evaluating the impact of influenza vaccination. A North American perspective.
    Fedson DS
    Pharmacoeconomics; 1996; 9 Suppl 3():54-61. PubMed ID: 10160488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of influenza vaccination. Assessment for The Netherlands.
    Postma MJ; Bos JM; van Gennep M; Jager JC; Baltussen R; Sprenger MJ
    Pharmacoeconomics; 1999; 16 Suppl 1():33-40. PubMed ID: 10623374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. French economic evaluations of influenza and influenza vaccination.
    Levy E
    Pharmacoeconomics; 1996; 9 Suppl 3():62-6. PubMed ID: 10160489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization.
    Mullooly JP; Bennett MD; Hornbrook MC; Barker WH; Williams WW; Patriarca PA; Rhodes PH
    Ann Intern Med; 1994 Dec; 121(12):947-52. PubMed ID: 7978721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of influenza vaccination of healthy children.
    Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
    Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza cost and cost-effectiveness studies globally--a review.
    Peasah SK; Azziz-Baumgartner E; Breese J; Meltzer MI; Widdowson MA
    Vaccine; 2013 Nov; 31(46):5339-48. PubMed ID: 24055351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of influenza vaccination in working-age cancer patients.
    Avritscher EB; Cooksley CD; Geraci JM; Bekele BN; Cantor SB; Rolston KV; Elting LS
    Cancer; 2007 Jun; 109(11):2357-64. PubMed ID: 17457827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and effectiveness of influenza vaccination: a systematic review.
    D'Angiolella LS; Lafranconi A; Cortesi PA; Rota S; Cesana G; Mantovani LG
    Ann Ist Super Sanita; 2018; 54(1):49-57. PubMed ID: 29616674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.
    Postma MJ; Jansema P; van Genugten ML; Heijnen ML; Jager JC; de Jong-van den Berg LT
    Drugs; 2002; 62(7):1013-24. PubMed ID: 11985488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of influenza vaccine in the elderly.
    Nichol KL; Margolis KL; Wouremna J; von Sternberg T
    Gerontology; 1996; 42(5):274-9. PubMed ID: 8940650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness Analysis of a Television Campaign to Promote Seasonal Influenza Vaccination Among the Elderly.
    Kim M; Yoo BK
    Value Health; 2015 Jul; 18(5):622-30. PubMed ID: 26297090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain.
    García A; Ortiz de Lejarazu R; Reina J; Callejo D; Cuervo J; Morano Larragueta R
    Hum Vaccin Immunother; 2016 Sep; 12(9):2269-77. PubMed ID: 27184622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland.
    Nagy L; Heikkinen T; Sackeyfio A; Pitman R
    Pharmacoeconomics; 2016 Sep; 34(9):939-51. PubMed ID: 27423657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities.
    You JH; Wong WC; Ip M; Lee NL; Ho SC
    J Epidemiol Community Health; 2009 Nov; 63(11):906-11. PubMed ID: 19608558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the effectiveness and cost-benefit of influenza vaccine on elderly population in Beijing city].
    Liu M; Liu GF; Wang Y; Zhao W; Wang L; Shi W; Wen SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jun; 26(6):412-6. PubMed ID: 16185449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the U.K.
    Meier G; Gregg M; Poulsen Nautrup B
    J Med Econ; 2015; 18(9):746-61. PubMed ID: 25903831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
    Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
    Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination of healthy children against seasonal influenza: a European perspective.
    Heikkinen T; Tsolia M; Finn A
    Pediatr Infect Dis J; 2013 Aug; 32(8):881-8. PubMed ID: 23856713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic value of influenza vaccination.
    de Waure C; Veneziano MA; Cadeddu C; Capizzi S; Specchia ML; Capri S; Ricciardi W
    Hum Vaccin Immunother; 2012 Jan; 8(1):119-29. PubMed ID: 22251999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.